Format

Send to

Choose Destination
See comment in PubMed Commons below
J Assist Reprod Genet. 2012 Oct;29(10):1123-34. doi: 10.1007/s10815-012-9841-8. Epub 2012 Aug 14.

Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy.

Author information

1
Service d'Histologie, Embryologie, Biologie de la Reproduction, Cytogénétique et Génétique Médicale, Centre Hospitalier Poissy St Germain en Laye, ART Center, Poissy and EA2493, Paris Ile de France, Ouest Faculty, Versailles University, 10, rue du Champ Gaillard, 78303 Poissy, France. ibhammoud@yahoo.com

Abstract

PURPOSE:

Our objective was to identify a marker for oocyte aneuploidy in follicular fluid (FF) in women with an increased risk of oocyte aneuploidy after controlled ovarian hyperstimulation.

MATERIALS AND METHODS:

Three groups of oocytes were constituted for polar body screening by FISH (chromosomes 13, 16, 18, 21 and 22): Group 1, advanced maternal age (n = 156); Group 2, implantation failure (i.e. no pregnancy after the transfer of more than 10 embryos; n = 101) and Group 3, implantation failure and advanced maternal age (n = 56). FSH and other proteins were assayed in the corresponding FF samples.

RESULTS:

Of the 313 oocytes assessed, 35.78 % were abnormal. We found a significant difference between the follicular FSH levels in normal oocytes and abnormal oocytes (4.85 ± 1.75 IU/L vs. 5.41 ± 2.47 IU/L, respectively; p = 0.021). We found that the greater the number of chromosomal abnormalities per oocyte (between 0 and 3), the higher the follicular FSH level.

CONCLUSION:

High FF FSH levels were associated with oocyte aneuploidy in women having undergone controlled ovarian hyperstimulation.

PMID:
22890422
PMCID:
PMC3492586
DOI:
10.1007/s10815-012-9841-8
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center